Lanasa, M. C., Allgood, S. D., Slager, S. L., Camp, N., Spector, L., Rassenti, L., … Levesque, M. C. (2008). Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL. BLOOD, 112(11), 1078–1078.

Lanasa, Mark C., Sallie D. Allgood, Susan L. Slager, Nicola Camp, Logan Spector, Laura Rassenti, Neil E. Kay, et al. “Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL.” BLOOD 112, no. 11 (2008): 1078–1078.

Lanasa MC, Allgood SD, Slager SL, Camp N, Spector L, Rassenti L, et al. Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL. BLOOD. 2008;112(11):1078–1078.

Lanasa, Mark C., et al. “Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL.” BLOOD, vol. 112, no. 11, 2008, pp. 1078–1078.

Lanasa MC, Allgood SD, Slager SL, Camp N, Spector L, Rassenti L, Kay NE, Gockerman JP, Volkheimer A, Goodman BK, Strom S, Call T, Cerhan J, Leis JF, Goldin L, Marti G, Weinberg JB, Caporaso N, Levesque MC. Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL. BLOOD. 2008;112(11):1078–1078.